Labeler
A-S Medication Solutions NDC Codes
A-S Medication Solutions lists 2,779 finished drug products in the FDA NDC Directory under NDC labeler code 50090.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine Sodium, Rosuvastatin Calcium, Sertraline Hydrochloride, Trazodone Hydrochloride, Fluoxetine, Metformin Hydrochloride, Diclofenac Sodium, Bumetanide, Diclofenac Sodium Delayed Release, Doxycycline Hyclate, Atorvastatin Calcium, Dapagliflozin, Amlodipine Besylate, Fenofibrate, Hydrochlorothiazide
- Active ingredients
- Levothyroxine sodium, Rosuvastatin calcium, Diclofenac sodium, Sertraline hydrochloride, Trazodone hydrochloride, Fluoxetine hydrochloride, Metformin hydrochloride, Bumetanide, Doxycycline hyclate, Atorvastatin calcium trihydrate, Dapagliflozin, Amlodipine besylate
- NDC labeler codes
- 50090
- Strengths (from the 100 most recently listed products)
- Diclofenac sodium 75 mg/1; Rosuvastatin calcium 10 mg/1; Rosuvastatin calcium 5 mg/1; Doxycycline hyclate 100 mg/1; Trazodone hydrochloride 50 mg/1; Trazodone hydrochloride 100 mg/1; Amlodipine besylate 2.5 mg/1; Fenofibrate 160 mg/1; Fluoxetine hydrochloride 40 mg/1; Fluoxetine hydrochloride 20 mg/1; Metformin hydrochloride 1000 mg/1; Metformin hydrochloride 500 mg/1; Sertraline hydrochloride 50 mg/1; Sertraline hydrochloride 100 mg/1; Sertraline hydrochloride 25 mg/1; Hydrochlorothiazide 12.5 mg/1; Levothyroxine sodium 50 ug/1; Levothyroxine sodium 88 ug/1; Levothyroxine sodium 100 ug/1; Levothyroxine sodium 137 ug/1
- Dosage forms
- Tablet, Tablet, Film coated, Tablet, Delayed release, Capsule, Injection, Solution, Film, Ointment, Kit, Aerosol, Powder, Insert, Extended release, Tablet, Extended release, Syrup, Solution, Shampoo, Suspension, Cream, Suspension/ drops
- Routes
- Oral, Topical, Intramuscular, Respiratory (Inhalation), Percutaneous, Vaginal, Subcutaneous, Ophthalmic
- Drug classes (FDA established)
- Serotonin Reuptake Inhibitor, HMG-CoA Reductase Inhibitor, l-Thyroxine, Nonsteroidal Anti-inflammatory Drug, Biguanide, Loop Diuretic, Corticosteroid, Tetracycline-class Drug, Sodium-Glucose Cotransporter 2 Inhibitor, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Peroxisome Proliferator Receptor alpha Agonist, Thiazide Diuretic, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Phenothiazine, Angiotensin Converting Enzyme Inhibitor, Amide Local Anesthetic, Cholinergic Receptor Agonist, Partial Cholinergic Nicotinic Agonist, Androgen, Serotonin-1b and Serotonin-1d Receptor Agonist, Cholinergic Muscarinic Antagonist, Phosphodiesterase 5 Inhibitor, Tricyclic Antidepressant, Estrogen, Progestin, Expectorant, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Histamine-1 Receptor Antagonist, Azole Antifungal, Cyclooxygenase Inhibitor, Antiarrhythmic, Central alpha-2 Adrenergic Agonist, Antimycobacterial, Ergot Derivative
- HCPCS / J-code
- CPT 90750 — Vaccine product code for SHINGRIX (zoster vaccine recombinant, adjuvanted), J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 187 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost 50 ug/mL | SolutionOphthalmic | 50090-7062 | 50090-7062-00 | — |
| Torsemide | Torsemide 20 mg/1 | TabletOral | 50090-7261 | 50090-7261-00 | — |
| Torsemide | Torsemide 100 mg/1 | TabletOral | 50090-7425 | 50090-7425-00 | — |
| Baclofen | Baclofen 10 mg/1 | TabletOral | 50090-7913 | 50090-7913-00 | — |
| Diclofenac Sodium | Diclofenac sodium 50 mg/1 | Tablet, Delayed releaseOral | 50090-0540 | 50090-0540-0050090-0540-0250090-0540-05 | — |
| Diclofenac Sodium | Diclofenac sodium 50 mg/1 | Tablet, Delayed releaseOral | 50090-0541 | 50090-0541-0050090-0541-01 | — |
| Levonestlevonorgestrel and ethinyl estradiol | — | Kit | 50090-2505 | 50090-2505-00 | — |
| Azithromycin | Azithromycin dihydrate 100 mg/5mL | Powder, For suspensionOral | 50090-1868 | 50090-1868-00 | — |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | 50090-1048 | 50090-1048-0050090-1048-01 | — |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | Tablet, Film coated, Extended releaseOral | 50090-1470 | 50090-1470-00 | — |
| Indomethacin | Indomethacin 25 mg/1 | CapsuleOral | 50090-0054 | 50090-0054-0050090-0054-0150090-0054-03+1 more | — |
| Indomethacin | Indomethacin 25 mg/1 | CapsuleOral | 50090-0055 | 50090-0055-00 | — |
| Indomethacin | Indomethacin 50 mg/1 | CapsuleOral | 50090-2803 | 50090-2803-00 | — |
| Indomethacin | Indomethacin 50 mg/1 | CapsuleOral | 50090-2987 | 50090-2987-0050090-2987-0150090-2987-03 | — |
| Gemfibrozil | Gemfibrozil 600 mg/1 | TabletOral | 50090-6913 | 50090-6913-0050090-6913-0250090-6913-03+1 more | — |
| Gemfibrozil | Gemfibrozil 600 mg/1 | TabletOral | 50090-6939 | 50090-6939-00 | — |
| Tenivacclostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 2 [Lf]/.5mL | Injection, SuspensionIntramuscular | 50090-2062 | 50090-2062-00 | — |
| Lo Loestrin Fenorethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate | — | Kit | 50090-1456 | 50090-1456-00 | — |
| Cefuroxime axetil | Cefuroxime axetil 500 mg/1 | Tablet, Film coatedOral | 50090-2157 | 50090-2157-00 | — |
| Cefuroxime axetil | Cefuroxime axetil 250 mg/1 | Tablet, Film coatedOral | 50090-2158 | 50090-2158-0050090-2158-03 | — |
| Cefuroxime axetil | Cefuroxime axetil 250 mg/1 | Tablet, Film coatedOral | 50090-2159 | 50090-2159-0050090-2159-01 | — |
| Loratadine | Loratadine 5 mg/5mL | SolutionOral | 50090-1454 | 50090-1454-00 | — |
| NP Thyroid 60levothyroxine, liothyronine | Levothyroxine 38 ug/1; Liothyronine 9 ug/1 | TabletOral | 50090-5216 | 50090-5216-00 | — |
| Ipratropium Bromide | Ipratropium bromide .5 mg/2.5mL | SolutionRespiratory (Inhalation) | 50090-6373 | 50090-6373-00 | — |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | 50090-1627 | 50090-1627-0050090-1627-0150090-1627-02+1 more | — |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | 50090-2524 | 50090-2524-0050090-2524-0150090-2524-02 | — |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | 50090-2581 | 50090-2581-0050090-2581-0150090-2581-02 | — |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | 50090-5059 | 50090-5059-00 | — |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | 50090-5550 | 50090-5550-00 | — |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | 50090-6853 | 50090-6853-00 | — |
| Baclofen | Baclofen 10 mg/1 | TabletOral | 50090-6868 | 50090-6868-0050090-6868-0150090-6868-03 | — |
| Baclofen | Baclofen 10 mg/1 | TabletOral | 50090-6869 | 50090-6869-00 | — |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed releaseOral | 50090-6830 | 50090-6830-00 | — |
| Levetiracetam | Levetiracetam 500 mg/1 | Tablet, Film coatedOral | 50090-1333 | 50090-1333-0050090-1333-0150090-1333-02+1 more | — |
| Levetiracetam | Levetiracetam 1000 mg/1 | Tablet, Film coatedOral | 50090-2875 | 50090-2875-0150090-2875-02 | — |
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | TabletOral | 50090-7816 | 50090-7816-00 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 50090-1641 | 50090-1641-0050090-1641-0150090-1641-02 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 50090-1745 | 50090-1745-0050090-1745-0150090-1745-02 | — |
| Losartan Potassium | Losartan potassium 25 mg/1 | Tablet, Film coatedOral | 50090-2622 | 50090-2622-0050090-2622-0150090-2622-02 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 50090-2632 | 50090-2632-0050090-2632-01 | — |
| Losartan Potassium and Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1; Losartan potassium 100 mg/1 | TabletOral | 50090-4993 | 50090-4993-0050090-4993-0150090-4993-02 | — |
| Losartan Potassium | Losartan potassium 25 mg/1 | Tablet, Film coatedOral | 50090-6714 | 50090-6714-00 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 50090-7199 | 50090-7199-00 | — |
| Losartan Potassium and Hydrochlorothiazide | Losartan potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 50090-7237 | 50090-7237-00 | — |
| Losartan Potassium and Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1; Losartan potassium 100 mg/1 | TabletOral | 50090-7664 | 50090-7664-00 | — |
| Glyburide | Glyburide 5 mg/1 | TabletOral | 50090-0495 | 50090-0495-0050090-0495-0150090-0495-02+2 more | — |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | 50090-5776 | 50090-5776-0050090-5776-02 | — |
| Phendimetrazine Tartrate | Phendimetrazine tartrate 35 mg/1 | TabletOral | 50090-0715 | 50090-0715-0050090-0715-0150090-0715-02+1 more | — |
| Phendimetrazine Tartrate | Phendimetrazine tartrate 35 mg/1 | TabletOral | 50090-2235 | 50090-2235-02 | — |
| Phendimetrazine Tartrate | Phendimetrazine tartrate 35 mg/1 | TabletOral | 50090-6552 | 50090-6552-0250090-6552-09 | — |
A-S Medication Solutions: common questions
- What is A-S Medication Solutions's NDC labeler code?
- 50090. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for A-S Medication Solutions?
- Med-Code's HCPCS directory matches CPT 90750, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.